|
Delayed
London S.E.
|
5-day change | 1st Jan Change | ||
| - GBX | -.--% |
|
+0.65% | -29.32% |
| 14/12/17 | Vernalis : AGM Statement | PU |
| 14/12/17 | Vernalis PLC: AGM Statement | MW |
| 13/12/17 | Vernalis : enters into research collaboration with Daiichi Sankyo | PU |
| 13/12/17 | Vernalis : + Daiichi Sankyo Enter Collaboration | MW |
| 06/12/17 | Vernalis : and Servier Achieve Research Milestone in Third Oncology Collaboration | PU |
| Director | Title | Age | Since |
|---|---|---|---|
Todd Davis
BRD | Director/Board Member | 65 | 05/12/2022 |
Octavio Espinoza
BRD | Director/Board Member | 56 | 01/11/2022 |
Andrew Reardon
BRD | Director/Board Member | 52 | 01/11/2022 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | +0.65% | - | - | 0 | |
| -0.71% | -6.35% | -2.99% | +9.59% | 45.48B | |
| +0.21% | -2.98% | +337.74% | +519.55% | 43.68B | |
| +1.74% | -2.24% | +39.82% | +20.76% | 43.09B | |
| +1.38% | -3.28% | +6.84% | +67.62% | 39.4B | |
| -1.44% | -5.26% | +8.97% | +39.76% | 31.91B | |
| +0.87% | -2.60% | - | - | 17.31B | |
| +0.75% | -0.64% | +19.75% | +110.17% | 16.4B | |
| -0.31% | -2.78% | +10.78% | +31.02% | 14.24B | |
| +1.93% | -3.55% | +82.00% | +41.17% | 13.28B | |
| Average | +0.44% | -3.57% | +62.86% | +104.96% | 29.42B | |
| Weighted average by Cap. | +0.41% | -3.67% | +74.57% | +124.26% |
- Stock Market
- Stocks
- VER Stock
Select your edition
All financial news and data tailored to specific country editions
